PACTR202203690920424Completed未知
Effect of pre-meal metformin with or without an acute exercise bout on postprandial lipemia in metabolic syndrome patients
Faculty of medicine of sousse0 sites15 target enrollmentStarted: March 17, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 19 Year(s) to 44 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •?Increased waist circumference (=102 cm in men; =88 cm in women)
- •?Elevated triglycerides (=150 mg/dl), or on medication for treating the condition
- •?Reduced HDL-cholesterol (<40mg/dl in men, <50 mg/dl in women), or on medication for treating the condition
- •?High blood pressure (=130 mmHg systolic or =85mmHg diastolic), or on medication for treating the condition
- •?Elevated fasting glucose (=100 mg/dl), or on medication for treating the condition
Exclusion Criteria
- •Any condition that counter-indicate exercise
- •Patients under glucose lowering agents
Investigators
Similar Trials
Recruiting
Phase 3
Effect of using metformin on the incidence of gestational diabetes and preeclampsia in pregnant women with polycystic ovaryPre-eclampsiaIRCT20120215009014N252Hamedan University of Medical Sciences170
Recruiting
Phase 3
The effect of metformin in patients with ovarian cancerSerum CA125 changes.Elevated cancer antigen 125 [CA 125]R97.1IRCT20120922010901N7Tabriz University of Medical Sciences90
Recruiting
Phase 3
Treatment Of Endometrial HyperplasiaEndometrial Hyperplasia.Endometrial hyperplasiaN85.0IRCT20221015056181N1Ghoum University of Medical Sciences134
Suspended
Phase 1
A Randomised Double-Blind Controlled Trial of Metformin and Atorvastatin – with treatment commenced following prostatic biopsy and ceasing just before radical prostatectomy - to guide subsequent patient managementCancer - ProstateProstate cancerACTRN12615000571572niversity of Queensland Centre for Clinical Research80
Recruiting
Phase 3
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50